APA (7th ed.) Citation

Gao, X., Liu, Z., Xu, Z., Liu, K., Zhang, Y., Yu, J., . . . Zhao, B. (2026). Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: An organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient. Cellular Oncology (2211-3428), 49(2), 1. https://doi.org/10.1007/s13402-026-01172-y

Chicago Style (17th ed.) Citation

Gao, Xinyu, et al. "Discover Personalized Drug Opportunity and Optimized Tumor-infiltrating Lymphocyte Therapy for Rare Cancer: An Organoid-based Whole-journey Clinical Mapping Study in a Neuroendocrine Cancer Patient." Cellular Oncology (2211-3428) 49, no. 2 (2026): 1. https://doi.org/10.1007/s13402-026-01172-y.

MLA (9th ed.) Citation

Gao, Xinyu, et al. "Discover Personalized Drug Opportunity and Optimized Tumor-infiltrating Lymphocyte Therapy for Rare Cancer: An Organoid-based Whole-journey Clinical Mapping Study in a Neuroendocrine Cancer Patient." Cellular Oncology (2211-3428), vol. 49, no. 2, 2026, p. 1, https://doi.org/10.1007/s13402-026-01172-y.